Free Newsletter
FDA experts mull ban on child cold meds
Did drug makers go far enough when they pulled infant cough-and-cold remedies from store shelves last week? Maybe not, the FDA says. An advisory panel convened to discuss the over-the-counter meds is weighing the evidence: that every study of pediatric cold products shows they don't work; that dosing is confusing; and that some research concludes the meds are dangerous. One FDA official told the committee to consider banning them.
Obviously, the drug industry doesn't want to lose these products. The Consumer Health Productions Association is promising an educational campaign to teach parents to use the products properly and avoid overdose. But another powerful group is set against them: pediatricians, who originally lobbied the FDA to take up the issue.
- read the New York Times report
Related Articles:
Drug makers recall infant cold meds. Report
FDA to review OTC cough medicine safety. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: